More than three years into the pandemic, uncertainties still remain about the ongoing and long-term impact on health caused by the Covid-19 infection and the pandemic situation. This includes sequelae of the acute infection such as "Long Covid" as well as cardiovascular risks (e.g., heart attacks and strokes), but also indirect effects such as disrupted medical care (e.g., delayed cancer treatments) as well as deteriorated mental and metabolic health. These and other mechanisms may already have impacted morbidity (and may do so in the future) and may therefore affect the disability insurance business.

Organised by the EAA – European Actuarial Academy GmbH.

The web session aims to be of interest for all persons dealing directly or indirectly with disability business or having an interest in this topic. As deep actuarial knowledge is not required, participation can be beneficial for all who want to learn more about the impact of the Covid-19 pandemic on disability business.

Technical Requirements
Please check with your IT department if your firewall and computer settings support web session participation (the programme Zoom will be used for this online training). Please also make sure that you are joining the web session with a stable internet connection.

This online training aims to give an understanding of the impact of Covid-19 on morbidity and disability insurance business. The above-mentioned aspects including "Long Covid" are explained, and the impact on disability business is analysed based on experience of Swiss Re from several countries with focus on the differential impact on short- and long-term disability products.

The language of the web session will be English.

Prof Dr Tobias Schiergens, Swiss Re
Tobias Schiergens is Medical Officer for the EMEA region (Europe, Middle East, Africa) and one of the Covid-19 experts at Swiss Re. He is the German Bureau Member of ICLAM (The International Committee For Insurance Medicine).
Tobias is a full Professor at the University of Munich (LMU), Germany, and has published more than 100 peer-reviewed scientific articles, reviews and books.

Sandra Portmann, Swiss Re
Sandra Portmann is heading the L&H Pricing team for Continental Europe at Swiss Re. In her role, Sandra is responsible for the biometric assumptions for mortality, disability and other Life and Health risks.
Sandra is a qualified actuary and member of the Swiss Actuarial Association (SAA), she holds a Master's degree in mathematics from the Swiss Federal Institute of Technology (ETH Zurich) and has over 16 years of experience in L&H pricing.